Yes. The 2023–2024 formula Novavax vaccine is an option for any person age 12 years or older who is unvaccinated or was previously vaccinated with any COVID-19 vaccine and is due for a 2023–2024 updated vaccination. The dose may be given at least 2 months after the most recent dose of a previous COVID-19 vaccine formulation. Any person age 12 years or older who has never had a dose of COVID-19 vaccine should receive two doses of Novavax vaccine, administered 3 to 8 weeks apart as a primary series. People with moderate to severe immunocompromise may receive a third dose at least 2 months following the second dose, and may receive subsequent additional doses at the discretion of their healthcare provider, in consideration of their individual circumstances. Additional details from FDA are available: www.fda.gov/vaccines-blood-biologics/coronavirus-covid-19-cber-regulated-biologics/novavax-covid-19-vaccine-adjuvanted.